These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 28379354)

  • 1. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
    Kim JK; Caine C; Awano T; Herbst R; Monani UR
    Hum Mol Genet; 2017 Jul; 26(13):2377-2385. PubMed ID: 28379354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
    Feng Z; Lam S; Tenn ES; Ghosh AS; Cantor S; Zhang W; Yen PF; Chen KS; Burden S; Paushkin S; Ayalon G; Ko CP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
    Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ
    J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
    Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO; De Repentigny Y; Tierney A; Beauvais A; Michaud J; Chehade L; Thabet M; Paul B; Reilly A; Gagnon S; Renaud JM; Kothary R
    EBioMedicine; 2020 May; 55():102750. PubMed ID: 32339936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.
    Kariya S; Park GH; Maeno-Hikichi Y; Leykekhman O; Lutz C; Arkovitz MS; Landmesser LT; Monani UR
    Hum Mol Genet; 2008 Aug; 17(16):2552-69. PubMed ID: 18492800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
    J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy.
    Lee AJ; Awano T; Park GH; Monani UR
    PLoS One; 2012; 7(9):e46353. PubMed ID: 23029491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMN controls neuromuscular junction integrity through U7 snRNP.
    Tisdale S; Van Alstyne M; Simon CM; Mentis GZ; Pellizzoni L
    Cell Rep; 2022 Sep; 40(12):111393. PubMed ID: 36130491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV9-DOK7 gene therapy reduces disease severity in Smn
    Kaifer KA; Villalón E; Smith CE; Simon ME; Marquez J; Hopkins AE; Morcos TI; Lorson CL
    Biochem Biophys Res Commun; 2020 Sep; 530(1):107-114. PubMed ID: 32828271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
    Goulet BB; Kothary R; Parks RJ
    Curr Mol Med; 2013 Aug; 13(7):1160-74. PubMed ID: 23514457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL; Chen TH; Hsu YY; Cheng YH; Juang BT; Jong YJ
    PLoS One; 2016; 11(4):e0154723. PubMed ID: 27124114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
    Murray LM; Comley LH; Thomson D; Parkinson N; Talbot K; Gillingwater TH
    Hum Mol Genet; 2008 Apr; 17(7):949-62. PubMed ID: 18065780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.
    Kim JK; Jha NN; Feng Z; Faleiro MR; Chiriboga CA; Wei-Lapierre L; Dirksen RT; Ko CP; Monani UR
    J Clin Invest; 2020 Mar; 130(3):1271-1287. PubMed ID: 32039917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A link between agrin signalling and Ca
    Delers P; Sapaly D; Salman B; De Waard S; De Waard M; Lefebvre S
    Sci Rep; 2022 Nov; 12(1):18960. PubMed ID: 36347955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy.
    Hunter G; Powis RA; Jones RA; Groen EJ; Shorrock HK; Lane FM; Zheng Y; Sherman DL; Brophy PJ; Gillingwater TH
    Hum Mol Genet; 2016 Jul; 25(13):2853-2861. PubMed ID: 27170316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling spinal muscular atrophy in Drosophila.
    Chang HC; Dimlich DN; Yokokura T; Mukherjee A; Kankel MW; Sen A; Sridhar V; Fulga TA; Hart AC; Van Vactor D; Artavanis-Tsakonas S
    PLoS One; 2008 Sep; 3(9):e3209. PubMed ID: 18791638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.
    Tejero R; Lopez-Manzaneda M; Arumugam S; Tabares L
    Hum Mol Genet; 2016 Nov; 25(21):4703-4716. PubMed ID: 28173138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.